TD Cowen Maintains Biote(BTMD.US) With Buy Rating, Maintains Target Price $8
TD Cowen Maintains Biote(BTMD.US) With Buy Rating, Raises Target Price to $8
Roth MKM Maintains Biote(BTMD.US) With Buy Rating, Cuts Target Price to $11
Biote (BTMD) Receives a Buy From Roth MKM
Truist Financial Maintains Biote(BTMD.US) With Buy Rating
TD Cowen Maintains Biote(BTMD.US) With Buy Rating, Maintains Target Price $7
TD Cowen Maintains Biote(BTMD.US) With Buy Rating, Maintains Target Price $7
Analysts Are Bullish on These Healthcare Stocks: Biote (BTMD), Ardent Health Partners, Inc. (ARDT)
Truist Financial Gives a Buy Rating to Biote (BTMD)
Truist Financial Sticks to Their Buy Rating for Biote (BTMD)
B. Riley Ups Price Target on Biote to $10 From $9, Maintains Buy Rating
Correction: --B. Riley Lowers Bitcoin Depot's Price Target to $4 From $6, Maintains Buy Rating
Biote Analyst Ratings
Analysts Are Bullish on Top Healthcare Stocks: Biote (BTMD), Incyte (INCY)
Truist Financial Issues a Buy Rating on Biote (BTMD)
Buy Rating on Biote's Stock: A Positive Outlook Amidst Nutraceutical Challenges
Biote Analyst Ratings
Biote Analyst Ratings
Biote Analyst Ratings
TD Cowen Maintains Outperform on Biote, Lowers Price Target to $7
No Data
No Data